Article

Investigation of genomic and transcriptomic risk factors in clopidogrel response in African Americans

2023-12-07

Abstract excerpt

Clopidogrel, an anti-platelet drug, used to prevent thrombosis after percutaneous coronary intervention. Clopidogrel resistance results in recurring ischemic episodes, with African Americans suffering disproportionately. The aim of this study was to identify biomarkers of clopidogrel resistance in African American patients. We conducted a genome-wide association study, including local ancestry adjustment, in 141 A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ca8c4e41-a2b2-5a7f-b4ef-3251e1bfb79d
DOI: 10.1101/2023.12.05.23299140

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Investigation of genomic and transcriptomic risk factors in clopidogrel response in African AmericansDOI 10.1101/2023.12.05.23299140Read

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Semantic proximity Read

Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients.Semantic proximity Read

The ABCD-GENE score influences vascular event rates in both users of clopidogrel and aspirin, as well as non-users of either drug in a population-based cohort studySemantic proximity Read

Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean HispanicsSemantic proximity Read

Ticagrelor responsive platelet genes are associated with platelet function and bleedingSemantic proximity Read

Clopidogrel pharmacogenetics: Beyond candidate genes and genome-wide association studies.Semantic proximity Read

Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.Semantic proximity Read

Non-Random Enrichment of Single Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: Role of AdmixtureSemantic proximity Read

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.Semantic proximity Read

Non-Random Enrichment of Single-Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: The Role of Admixture.Semantic proximity Read

Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary intervention.Semantic proximity Read

MirSNPs in clopidogrel metabolism genes predict cardiovascular disease risk: a case-control study and meta-analysis.Semantic proximity Read